Additionally, dipeptidyl peptidase-IV (DPP IV/CD26) is a cytokine-targeting surface enzyme which is considered a novel surface marker of CML Leukemic Stem Cell (LSC) [10]. The gene discussed is DPP4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.